Genscript Biotech (HK:1548) has released an update. Genscript Biotech’s subsidiary, Probio Nanjing, has entered into a significant license agreement with LaNova Medicines, granting exclusive rights to ...
Several Asian biopharma companies made waves at the American Society of Clinical Oncology annual meeting in Chicago. (Angus Liu/Fierce Pharma) AstraZeneca and Daiichi Sankyo are looking at moving ...
Good day, and thank you for standing by. Welcome to GenScript Biotech Interim Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would now ...
May 31 (Reuters) - The U.S. House of Representatives committee on China has asked the FBI and the intelligence community for a briefing on GenScript Biotechnology Co (1548.HK), opens new tab and three ...
"2025 was a year of accelerated growth and disciplined execution for GenScript," said Sherry Shao, Rotating CEO of GenScript Biotech Corporation. "We delivered strong results while continuing to ...
Genscript Biotech (HK:1548) has released an update. Genscript Biotech Corporation announced the unaudited financial results for the third quarter of 2024 for its associate, Legend Biotech Corporation, ...
Good day and thank you for standing by. Welcome to Genscript Biotech 2025 Interim Results Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results